Cell cycle dysregulation is a hallmark of NSCLC, with aberrations in regulators such as cyclins (e.g., CCND1) and cyclin-dependent kinases (CDKs) driving uncontrolled G1/S phase transition and genomic instability [58,59,60]. The gene discussed is CCND1; the disease is non-small cell lung carcinoma.